US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 1.7200
  • -0.0501-2.83%
Close Aug 29 16:00 ET
2.26MMarket Cap-91P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
-Cash and cash equivalents
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
Receivables
----
----
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
--12.89K
-Accrued interest receivable
----
----
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
--12.89K
Prepaid assets
-47.80%111.16K
-21.13%347.92K
-23.76%517.65K
-23.76%517.65K
-22.85%662.58K
-37.94%212.93K
-25.79%441.12K
-11.75%678.99K
-11.75%678.99K
-20.66%858.76K
Current deferred assets
--116.76K
----
----
----
----
----
----
----
----
--0
Other current assets
1.50%61.54K
21.38%98.16K
24.94%14.5K
24.94%14.5K
-19.67%29.25K
9.36%60.63K
2.28%80.87K
--11.6K
--11.6K
--36.41K
Total current assets
-39.90%5.24M
-44.27%5.18M
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
-34.42%8.97M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-39.90%5.24M
-44.27%5.18M
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
-34.42%8.97M
Liabilities
Current liabilities
Payables
203.16%1.33M
66.89%822.55K
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-37.17%483.74K
-accounts payable
203.16%1.33M
66.89%822.55K
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-37.17%483.74K
Current accrued expenses
396.35%313.28K
-45.38%318.41K
-83.92%41.1K
-83.92%41.1K
-82.51%113.31K
-86.28%63.12K
83.09%582.91K
8.56%255.54K
8.56%255.54K
80,883.38%647.87K
Current liabilities
180.94%1.92M
13.65%1.37M
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
25.86%1.5M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
180.94%1.92M
13.65%1.37M
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
25.86%1.5M
Shareholders'equity
Share capital
-78.37%69
178.66%666
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
45.26%1.21K
-common stock
-78.37%69
178.66%666
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
45.26%1.21K
Retained earnings
-19.82%-59.35M
-18.16%-56.52M
-17.10%-53.39M
-17.10%-53.39M
-16.69%-51.25M
-19.36%-49.53M
-23.38%-47.83M
-26.71%-45.59M
-26.71%-45.59M
-31.39%-43.92M
Paid-in capital
8.87%62.67M
7.88%60.33M
15.75%59.74M
15.75%59.74M
12.19%57.66M
12.52%57.56M
19.95%55.92M
11.99%51.61M
11.99%51.61M
11.92%51.39M
Total stockholders'equity
-58.68%3.32M
-52.92%3.81M
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
-83.73%7.47M
Total equity
-58.68%3.32M
-52.92%3.81M
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
-40.19%7.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -41.37%4.95M-46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M
-Cash and cash equivalents -41.37%4.95M-46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M
Receivables ---------33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K--12.89K
-Accrued interest receivable ---------33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K--12.89K
Prepaid assets -47.80%111.16K-21.13%347.92K-23.76%517.65K-23.76%517.65K-22.85%662.58K-37.94%212.93K-25.79%441.12K-11.75%678.99K-11.75%678.99K-20.66%858.76K
Current deferred assets --116.76K----------------------------------0
Other current assets 1.50%61.54K21.38%98.16K24.94%14.5K24.94%14.5K-19.67%29.25K9.36%60.63K2.28%80.87K--11.6K--11.6K--36.41K
Total current assets -39.90%5.24M-44.27%5.18M14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M-34.42%8.97M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -39.90%5.24M-44.27%5.18M14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M-34.42%8.97M
Liabilities
Current liabilities
Payables 203.16%1.33M66.89%822.55K74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K-37.17%483.74K
-accounts payable 203.16%1.33M66.89%822.55K74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K-37.17%483.74K
Current accrued expenses 396.35%313.28K-45.38%318.41K-83.92%41.1K-83.92%41.1K-82.51%113.31K-86.28%63.12K83.09%582.91K8.56%255.54K8.56%255.54K80,883.38%647.87K
Current liabilities 180.94%1.92M13.65%1.37M75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K25.86%1.5M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 180.94%1.92M13.65%1.37M75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K25.86%1.5M
Shareholders'equity
Share capital -78.37%69178.66%666410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%7745.26%1.21K
-common stock -78.37%69178.66%666410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%7745.26%1.21K
Retained earnings -19.82%-59.35M-18.16%-56.52M-17.10%-53.39M-17.10%-53.39M-16.69%-51.25M-19.36%-49.53M-23.38%-47.83M-26.71%-45.59M-26.71%-45.59M-31.39%-43.92M
Paid-in capital 8.87%62.67M7.88%60.33M15.75%59.74M15.75%59.74M12.19%57.66M12.52%57.56M19.95%55.92M11.99%51.61M11.99%51.61M11.92%51.39M
Total stockholders'equity -58.68%3.32M-52.92%3.81M5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M-83.73%7.47M
Total equity -58.68%3.32M-52.92%3.81M5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M-40.19%7.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg